AIDS Treatment Data Network
611 Broadway, Suite 613, New York, NY, 10012 • www.atdn.org • Tel: (212) 260-8868 • (NYS) 800-734-7104
The Access Project collects and distributes information about medications available for HIV/AIDS and hepatitis co-infection through Medicaid, Medicare Part D, AIDS Drug Assistance Programs (ADAPs), and pharmaceutical industry sponsored patient assistance and expanded access programs (EAP). The Access Project is a program of the The Network (network@atdn.org)

Amgen
Safety Net Program

Products covered:

Epogen (erythropoietin, EPO)
G-CSF, Neupogen (filgrastim) 1-800-272-9376




Contact
Program Eligibility
The patient must meet one of the two following criteria to qualify:
  • Annual income is below $60,000 for an individual and has no health insurance or Medicaid
Or
  • If insured, the patient must demonstrate difficulty with making co-payments for the drug by showing that at least 5% of their annual income is spent on the drug.
Enrollment Process
The doctor or the pharmacist must sign on with Amgen as a "sponsor"

Application is done over the phone. The applicant, the doctor, or the pharmacist can do this. Have income and insurance information available when you call. The process can take as little as 5 Minutes.
Re-Application
Once a patient is enrolled in the Safety Net Program they will not have to re-apply for 12 months.
Comments
If applying by mail the paper work can be processed within 30 days. After qualification the drug will arrive within 2 weeks. Amgen will replace used portions of the drug retroactively up to 6 months.

About The Network - Donate - About The Access Project
Last modified: 11/16/2007
© 2007 The Network